{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:36:30Z","timestamp":1787312190486,"version":"build-2736575974"},"reference-count":26,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCID"],"DOI":"10.2147\/ccid.s398950","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T09:55:07Z","timestamp":1678269307000},"page":"603-612","source":"Crossref","is-referenced-by-count":43,"title":["The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review"],"prefix":"10.2147","volume":"Volume 16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6700-8654","authenticated-orcid":true,"given":"Chaofan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbo","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1111\/jocd.14537","volume":"20","author":"Nestor","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1111\/jdv.15081","volume":"32","author":"Gupta","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jaad.2017.02.054","volume":"77","author":"Adil","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e14678","DOI":"10.1111\/dth.14678","volume":"34","author":"Abdel-Raouf","year":"2021","journal-title":"Dermatol Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1021\/acs.biomac.1c01691","volume":"23","author":"Gowda","year":"2022","journal-title":"Biomacromolecules"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000369404","volume":"47","author":"Ioannides","year":"2015","journal-title":"Curr Probl Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evid Based Med"},{"key":"ref10","first-page":"1","volume":"2022","author":"Ammar","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaad.2020.03.087","volume":"83","author":"Burns","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jaad.2015.06.063","volume":"73","author":"Famenini","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2022.905140","volume":"9","author":"Liang","year":"2022","journal-title":"Front Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","volume":"152","author":"Sinclair","year":"2005","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/ijd.13838","volume":"57","author":"Sinclair","year":"2018","journal-title":"Int J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jpainsymman.2016.12.320","volume":"53","author":"Carone","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/ced.14340","volume":"45","author":"Searle","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2133.2011.10630.x","volume":"165","author":"Sinclair","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijwd.2018.05.001","volume":"4","author":"Fabbrocini","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1440-0960.2007.00332.x","volume":"48","author":"Hoedemaker","year":"2007","journal-title":"Australas J Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jaad.2020.10.097","volume":"84","author":"Olamiju","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e15321","DOI":"10.1111\/dth.15321","volume":"35","author":"Aguilar Medina","year":"2022","journal-title":"Dermatol Ther"},{"key":"ref23","unstructured":"c26hx RBR. Oral minoxidil and spironolactone versus topical minoxidil for female pattern hair loss; 2017. Available from: https:\/\/trialsearchwhoint\/Trial2aspx?TrialID=RBR-6c26hx. Accessed March 6, 2023."},{"key":"ref24","unstructured":"Irct20211210053343N. Comparison of the effect of minoxidil and spironolactone with minoxidil and finasteride in the treatment of Androgenic Alopecia; 2021. Available from: https:\/\/trialsearchwhoint\/Trial2aspx?TrialID=IRCT20211210053343N1. Accessed March 6, 2023."},{"key":"ref25","unstructured":"Tctr. Efficacy and safety of oral spironolactone combined with 3% topical minoxidil for the treatment of female pattern hair loss in premenopausal women: a randomized, double- blind, placebo-controlled study; 2022. Available from: https:\/\/trialsearchwhoint\/Trial2aspx?TrialID=TCTR20220613005. Accessed March 6, 2023."},{"key":"ref26","first-page":"493","volume":"32","author":"Soliman","year":"2022","journal-title":"J Pak Assoc Dermatol"}],"container-title":["Clinical, Cosmetic and Investigational Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=87998","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=87998","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T09:55:15Z","timestamp":1678269315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/the-efficacy-and-safety-of-oral-and-topical-spironolactone-in-androgen-peer-reviewed-fulltext-article-CCID"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":26,"URL":"https:\/\/doi.org\/10.2147\/ccid.s398950","relation":{},"ISSN":["1178-7015"],"issn-type":[{"value":"1178-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}